Science in Boston
@scienceinboston.com
Your complete source for life science news and events in the Greater Boston Area. Brought to you by the Science in the City program at
@stemcell.com.
@stemcell.com.
We're having a great time at the Boston ISSCR PSC-Derived Therapies Symposium, but the fun isn't over! 🤩
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
December 12, 2025 at 12:45 PM
We're having a great time at the Boston ISSCR PSC-Derived Therapies Symposium, but the fun isn't over! 🤩
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
Thanks to everyone who attended our Innovation Showcase by Dr. Andrew Gaffney and Dr. Janet Rothberg from CCRM!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
December 12, 2025 at 12:55 AM
Thanks to everyone who attended our Innovation Showcase by Dr. Andrew Gaffney and Dr. Janet Rothberg from CCRM!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
The ISSCR PSC-Derived Therapies Symposium is buzzing already! 🤩 What's in store for today?
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
December 11, 2025 at 6:05 PM
The ISSCR PSC-Derived Therapies Symposium is buzzing already! 🤩 What's in store for today?
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
Glioblastoma is the most common form of brain cancer in adults, and its usually quick and fatal.
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
December 10, 2025 at 10:11 PM
Glioblastoma is the most common form of brain cancer in adults, and its usually quick and fatal.
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
Reposted by Science in Boston
Online & self-paced course designed for healthcare professionals, researchers, & medical students who are interested in learning more about genomic medicine. Free for Harvard affiliates & open to others for a fee: hvrdct.me/19a7ba
December 10, 2025 at 6:13 PM
Online & self-paced course designed for healthcare professionals, researchers, & medical students who are interested in learning more about genomic medicine. Free for Harvard affiliates & open to others for a fee: hvrdct.me/19a7ba
🚨 @mit.edu postdoc Dr. Arianna Bresci is the lead author of a new study that shows researchers can accurately measure blood glucose by shining near-infrared light on the skin.
This noninvasive imaging could replace finger pricks for people with #diabetes: https://bit.ly/48XasC5
This noninvasive imaging could replace finger pricks for people with #diabetes: https://bit.ly/48XasC5
December 10, 2025 at 12:14 AM
🚨 @mit.edu postdoc Dr. Arianna Bresci is the lead author of a new study that shows researchers can accurately measure blood glucose by shining near-infrared light on the skin.
This noninvasive imaging could replace finger pricks for people with #diabetes: https://bit.ly/48XasC5
This noninvasive imaging could replace finger pricks for people with #diabetes: https://bit.ly/48XasC5
A new study from researchers at @bumedicine.bsky.social shows that a treatment made up of #ExtracellularVesicles released by stem cells in bone marrow can slow and even reverse certain aspects of normal age-related #MemoryDecline.
Learn more: https://bit.ly/4oKIKx4
Learn more: https://bit.ly/4oKIKx4
December 8, 2025 at 10:45 PM
A new study from researchers at @bumedicine.bsky.social shows that a treatment made up of #ExtracellularVesicles released by stem cells in bone marrow can slow and even reverse certain aspects of normal age-related #MemoryDecline.
Learn more: https://bit.ly/4oKIKx4
Learn more: https://bit.ly/4oKIKx4
Dr. Naoshige Uchida at @harvardmcb.bsky.social was named the Jeff C.Tarr Professor of Molecular and Cellular Biology!
🧠 Dr. @naoshigeuchida.bsky.social is a leading neuroscientist whose work has reshaped our understanding of learning, decision-making, and sensory processing: https://bit.ly/4rurte6
🧠 Dr. @naoshigeuchida.bsky.social is a leading neuroscientist whose work has reshaped our understanding of learning, decision-making, and sensory processing: https://bit.ly/4rurte6
December 5, 2025 at 12:36 PM
Dr. Naoshige Uchida at @harvardmcb.bsky.social was named the Jeff C.Tarr Professor of Molecular and Cellular Biology!
🧠 Dr. @naoshigeuchida.bsky.social is a leading neuroscientist whose work has reshaped our understanding of learning, decision-making, and sensory processing: https://bit.ly/4rurte6
🧠 Dr. @naoshigeuchida.bsky.social is a leading neuroscientist whose work has reshaped our understanding of learning, decision-making, and sensory processing: https://bit.ly/4rurte6
✂️ #CRISPR research by Dr. George Church @geochurch.bsky.social inactivated all 62 copies of porcine endogenous retrovirus.
🐖 Now, eGenesis at @wyssinstitute.bsky.social & @harvardmed.bsky.social builds upon this work to develop safe pig organs for #xenotransplantation: https://bit.ly/4iAZKV7
🐖 Now, eGenesis at @wyssinstitute.bsky.social & @harvardmed.bsky.social builds upon this work to develop safe pig organs for #xenotransplantation: https://bit.ly/4iAZKV7
December 4, 2025 at 6:17 PM
✂️ #CRISPR research by Dr. George Church @geochurch.bsky.social inactivated all 62 copies of porcine endogenous retrovirus.
🐖 Now, eGenesis at @wyssinstitute.bsky.social & @harvardmed.bsky.social builds upon this work to develop safe pig organs for #xenotransplantation: https://bit.ly/4iAZKV7
🐖 Now, eGenesis at @wyssinstitute.bsky.social & @harvardmed.bsky.social builds upon this work to develop safe pig organs for #xenotransplantation: https://bit.ly/4iAZKV7
Reposted by Science in Boston
@aai.org invites you to submit abstracts of unpublished, original research for presentation at #IMMUNOLOGY2026™. This dynamic opportunity to showcase your research empowers you to connect, collaborate, advance your career, and access cutting-edge research. Submit & save today!
https://bit.ly/48cjOtl
https://bit.ly/48cjOtl
December 4, 2025 at 4:48 PM
@aai.org invites you to submit abstracts of unpublished, original research for presentation at #IMMUNOLOGY2026™. This dynamic opportunity to showcase your research empowers you to connect, collaborate, advance your career, and access cutting-edge research. Submit & save today!
https://bit.ly/48cjOtl
https://bit.ly/48cjOtl
Reposted by Science in Boston
Wyss startup Unravel Biosciences is now a clinical-stage therapeutics company! The Colombian Health Regulatory Agency, INVIMA, approved their RVL-001 clinical trial for Rett syndrome and Pitt-Hopkins syndrome. They've started enrolling patients and expect the trial to begin in January 2026.
www.businesswire.com
December 4, 2025 at 4:18 PM
Wyss startup Unravel Biosciences is now a clinical-stage therapeutics company! The Colombian Health Regulatory Agency, INVIMA, approved their RVL-001 clinical trial for Rett syndrome and Pitt-Hopkins syndrome. They've started enrolling patients and expect the trial to begin in January 2026.
Drs. Matthew Meyerson and Heidi Greulich from the @broadinstitute.org sit down and discuss how they and Bayer scientists developed the first FDA-approved #CancerDrug to come from a Broad scientific discovery.
🤝 Learn more about their academic-industry alliance: https://bit.ly/4ruQNRl
🤝 Learn more about their academic-industry alliance: https://bit.ly/4ruQNRl
December 3, 2025 at 10:40 PM
Drs. Matthew Meyerson and Heidi Greulich from the @broadinstitute.org sit down and discuss how they and Bayer scientists developed the first FDA-approved #CancerDrug to come from a Broad scientific discovery.
🤝 Learn more about their academic-industry alliance: https://bit.ly/4ruQNRl
🤝 Learn more about their academic-industry alliance: https://bit.ly/4ruQNRl
Reposted by Science in Boston
Nine Wyss Faculty and staff members made the Highly Cited Researchers 2025 list, which honors the top 1% of researchers around the world whose papers have been cited the most over the last decade.
We're so proud of their significant influence in their fields and impact on society. bit.ly/4aqYS3c
We're so proud of their significant influence in their fields and impact on society. bit.ly/4aqYS3c
December 3, 2025 at 4:02 PM
Nine Wyss Faculty and staff members made the Highly Cited Researchers 2025 list, which honors the top 1% of researchers around the world whose papers have been cited the most over the last decade.
We're so proud of their significant influence in their fields and impact on society. bit.ly/4aqYS3c
We're so proud of their significant influence in their fields and impact on society. bit.ly/4aqYS3c
After an extensive analysis by scientists at @mit.edu 's McGovern Institute, neuroscientists now have an atlas detailing #astrocytes’ dynamic diversity. 🗺️
Check out the work from Dr. Guoping Feng's lab. 👇
In the news: https://bit.ly/3MwwDWS
In @cellpress.bsky.social Neuron: https://bit.ly/3XtLDY6
Check out the work from Dr. Guoping Feng's lab. 👇
In the news: https://bit.ly/3MwwDWS
In @cellpress.bsky.social Neuron: https://bit.ly/3XtLDY6
December 2, 2025 at 9:41 PM
After an extensive analysis by scientists at @mit.edu 's McGovern Institute, neuroscientists now have an atlas detailing #astrocytes’ dynamic diversity. 🗺️
Check out the work from Dr. Guoping Feng's lab. 👇
In the news: https://bit.ly/3MwwDWS
In @cellpress.bsky.social Neuron: https://bit.ly/3XtLDY6
Check out the work from Dr. Guoping Feng's lab. 👇
In the news: https://bit.ly/3MwwDWS
In @cellpress.bsky.social Neuron: https://bit.ly/3XtLDY6
Reposted by Science in Boston
"I don't think you make disruptive advances by just following linear paths in your own field," explains Don Ingber.
In this episode of Talking About Blood, he discusses organ chips, their applications, and his transdisciplinary career journey.
In this episode of Talking About Blood, he discusses organ chips, their applications, and his transdisciplinary career journey.
Organs on Chips: Using Science, Art, and Design to Understand the Human Body - Talking About Blood
In this episode, Wyss Founding Director Don Ingber, M.D., Ph.D., talks with Helen Osborne about: How organ-on-chip and “human body on chips” technologies are built and how they realistically mimic hum...
wyss.harvard.edu
December 1, 2025 at 4:26 PM
"I don't think you make disruptive advances by just following linear paths in your own field," explains Don Ingber.
In this episode of Talking About Blood, he discusses organ chips, their applications, and his transdisciplinary career journey.
In this episode of Talking About Blood, he discusses organ chips, their applications, and his transdisciplinary career journey.
We’re thrilled to be part of the #ISSCR2025 Boston International Symposium in less than two weeks!
Get prepped by listening to Dr. Stefan Irion, one of the symposium organizers, sit down with our friends at the @stemcellpodcast.com : https://bit.ly/49B11cp
Get prepped by listening to Dr. Stefan Irion, one of the symposium organizers, sit down with our friends at the @stemcellpodcast.com : https://bit.ly/49B11cp
December 1, 2025 at 5:31 PM
We’re thrilled to be part of the #ISSCR2025 Boston International Symposium in less than two weeks!
Get prepped by listening to Dr. Stefan Irion, one of the symposium organizers, sit down with our friends at the @stemcellpodcast.com : https://bit.ly/49B11cp
Get prepped by listening to Dr. Stefan Irion, one of the symposium organizers, sit down with our friends at the @stemcellpodcast.com : https://bit.ly/49B11cp
🥳 @harvardmcb.bsky.social postdoc Dr. Rebecka Sepela has been selected as one of the 2025 L’Oréal USA For #WomenInScience Fellows.
This prestigious honor recognizes early-career scientists whose research, mentoring, and outreach efforts are shaping the future of STEM: https://bit.ly/48dvLh5
This prestigious honor recognizes early-career scientists whose research, mentoring, and outreach efforts are shaping the future of STEM: https://bit.ly/48dvLh5
November 28, 2025 at 6:43 PM
🥳 @harvardmcb.bsky.social postdoc Dr. Rebecka Sepela has been selected as one of the 2025 L’Oréal USA For #WomenInScience Fellows.
This prestigious honor recognizes early-career scientists whose research, mentoring, and outreach efforts are shaping the future of STEM: https://bit.ly/48dvLh5
This prestigious honor recognizes early-career scientists whose research, mentoring, and outreach efforts are shaping the future of STEM: https://bit.ly/48dvLh5
Reposted by Science in Boston
The Earth is in crisis, and we need solutions. The Wyss' Sustainable Futures Initiative is tackling this Grand Challenge by re-designing the systems we rely on, from farming to materials and manufacturing, to become planet-friendly with high-performance and scalable features.
Sustainable Futures: creating a healthy planet for all
By Seth Kroll The planet’s health directly impacts human health. Plastic pollution, unsustainable manufacturing, and carbon-intensive material production are accelerating a planetary crisis that…
buff.ly
November 26, 2025 at 4:12 PM
The Earth is in crisis, and we need solutions. The Wyss' Sustainable Futures Initiative is tackling this Grand Challenge by re-designing the systems we rely on, from farming to materials and manufacturing, to become planet-friendly with high-performance and scalable features.
🤓 New tech alert!
3DModeler is a new software program developed by Dr. Ata Kiapour and colleagues at @bostonchildrens.bsky.social . It uses 3D imaging and AI to support the diagnosis and treatment of hip conditions: https://on.bchil.org/44wYDjj
#Orthopedics
3DModeler is a new software program developed by Dr. Ata Kiapour and colleagues at @bostonchildrens.bsky.social . It uses 3D imaging and AI to support the diagnosis and treatment of hip conditions: https://on.bchil.org/44wYDjj
#Orthopedics
November 26, 2025 at 6:48 PM
🤓 New tech alert!
3DModeler is a new software program developed by Dr. Ata Kiapour and colleagues at @bostonchildrens.bsky.social . It uses 3D imaging and AI to support the diagnosis and treatment of hip conditions: https://on.bchil.org/44wYDjj
#Orthopedics
3DModeler is a new software program developed by Dr. Ata Kiapour and colleagues at @bostonchildrens.bsky.social . It uses 3D imaging and AI to support the diagnosis and treatment of hip conditions: https://on.bchil.org/44wYDjj
#Orthopedics
Reposted by Science in Boston
Jacqueline Garcia, MD, is exploring ongoing clinical research to test novel triplet therapies for safety and efficacy with a precision medicine approach for patients with acute myeloid leukemia. Explore the latest updates: bit.ly/3LmZEUC
November 25, 2025 at 5:30 PM
Jacqueline Garcia, MD, is exploring ongoing clinical research to test novel triplet therapies for safety and efficacy with a precision medicine approach for patients with acute myeloid leukemia. Explore the latest updates: bit.ly/3LmZEUC
The John D. and Catherine T. MacArthur Foundation has awarded a $100 million, 5-year grant to the Sentinel project at @broadinstitute.org.
😷 Drs. Christian Happi & Pardis Sabeti will create a system to detect outbreaks in real time, preventing them from becoming pandemics: https://bit.ly/483My7H
😷 Drs. Christian Happi & Pardis Sabeti will create a system to detect outbreaks in real time, preventing them from becoming pandemics: https://bit.ly/483My7H
November 25, 2025 at 7:50 PM
The John D. and Catherine T. MacArthur Foundation has awarded a $100 million, 5-year grant to the Sentinel project at @broadinstitute.org.
😷 Drs. Christian Happi & Pardis Sabeti will create a system to detect outbreaks in real time, preventing them from becoming pandemics: https://bit.ly/483My7H
😷 Drs. Christian Happi & Pardis Sabeti will create a system to detect outbreaks in real time, preventing them from becoming pandemics: https://bit.ly/483My7H
Are you heading to the #ISSCR2025 Boston International Symposium on December 11–12?
👋 Come say hello to our team and learn how we’re supporting innovation in stem cell science.
Stay tuned for details on where to find us, what we’ll be presenting, and how you can engage with us.
👋 Come say hello to our team and learn how we’re supporting innovation in stem cell science.
Stay tuned for details on where to find us, what we’ll be presenting, and how you can engage with us.
November 25, 2025 at 12:30 AM
Are you heading to the #ISSCR2025 Boston International Symposium on December 11–12?
👋 Come say hello to our team and learn how we’re supporting innovation in stem cell science.
Stay tuned for details on where to find us, what we’ll be presenting, and how you can engage with us.
👋 Come say hello to our team and learn how we’re supporting innovation in stem cell science.
Stay tuned for details on where to find us, what we’ll be presenting, and how you can engage with us.
Reposted by Science in Boston
Join us Saturday, December 6, for Careers of Tomorrow where we will focus on supporting equitable workforce development in STEM careers. The showcase includes a job fair, mentorship opportunities, panels, talks, activities, headshots, and more. Learn more: https://bit.ly/3XgcmXT
November 24, 2025 at 8:54 PM
Join us Saturday, December 6, for Careers of Tomorrow where we will focus on supporting equitable workforce development in STEM careers. The showcase includes a job fair, mentorship opportunities, panels, talks, activities, headshots, and more. Learn more: https://bit.ly/3XgcmXT
A general strategy for tackling diseases caused by premature stop codons is using suppressor tRNAs (sup-tRNAs).
Sarah Pierce & the Liu lab at the @broadinstitute.org have developed PERT, a strategy to rescue nonsense mutations by converting tRNA to sup-tRNA: https://go.nature.com/47UuKf7
Sarah Pierce & the Liu lab at the @broadinstitute.org have developed PERT, a strategy to rescue nonsense mutations by converting tRNA to sup-tRNA: https://go.nature.com/47UuKf7
November 21, 2025 at 8:29 PM
A general strategy for tackling diseases caused by premature stop codons is using suppressor tRNAs (sup-tRNAs).
Sarah Pierce & the Liu lab at the @broadinstitute.org have developed PERT, a strategy to rescue nonsense mutations by converting tRNA to sup-tRNA: https://go.nature.com/47UuKf7
Sarah Pierce & the Liu lab at the @broadinstitute.org have developed PERT, a strategy to rescue nonsense mutations by converting tRNA to sup-tRNA: https://go.nature.com/47UuKf7
🤩 @harvardmed.bsky.social has announced 10 recipients of the Blavatnik Institute Early Career Investigator Awards. Totaling $5 million, these grants are designed to fuel high-potential research conducted by exceptional junior faculty members.
Congratulations to all awardees! https://bit.ly/4aaK7RU
Congratulations to all awardees! https://bit.ly/4aaK7RU
November 21, 2025 at 12:30 AM
🤩 @harvardmed.bsky.social has announced 10 recipients of the Blavatnik Institute Early Career Investigator Awards. Totaling $5 million, these grants are designed to fuel high-potential research conducted by exceptional junior faculty members.
Congratulations to all awardees! https://bit.ly/4aaK7RU
Congratulations to all awardees! https://bit.ly/4aaK7RU